These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20667484)

  • 21. Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience.
    Lateef A; Lahiri M; Teng GG; Vasoo S
    Lupus; 2010 May; 19(6):765-70. PubMed ID: 20118162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
    Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus.
    Ikeda F; Watanabe S; Aizawa-Yashiro T; Tsuruga K; Ito E; Tanaka H
    Lupus; 2013 Dec; 22(14):1541-3. PubMed ID: 23966305
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.
    Iwata S; Saito K; Tokunaga M; Tanaka Y
    Lupus; 2013 Apr; 22(5):538-40. PubMed ID: 23423251
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
    Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I
    Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.
    Looney RJ; Anolik JH; Campbell D; Felgar RE; Young F; Arend LJ; Sloand JA; Rosenblatt J; Sanz I
    Arthritis Rheum; 2004 Aug; 50(8):2580-9. PubMed ID: 15334472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 29. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab.
    Tektonidou MG
    Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New biological therapy in systemic lupus erythematosus].
    Morita K; Fujio K
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():539-44. PubMed ID: 23513898
    [No Abstract]   [Full Text] [Related]  

  • 32. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab.
    Simonetta F; Posa M; Villard J; Marceau-Renaut A; Preudhomme C; Samii K; Chizzolini C
    Ann Hematol; 2015 Jul; 94(7):1247-9. PubMed ID: 25847363
    [No Abstract]   [Full Text] [Related]  

  • 34. [Belimumab--the biological treatment for systemic lupus erythematosus--first in 50 years].
    Vadasz Z; Toubi E
    Harefuah; 2011 Dec; 150(12):880-3. PubMed ID: 22352276
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of immunosorption in patients with systemic lupus erythematosus: double blind controlled trial].
    Amosova EN; Iaremenko OB; Snezhkova EA; Drannik GV
    Ter Arkh; 1997; 69(12):18-22. PubMed ID: 9503527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient.
    Wang Y; Zhou W; Zhang Z
    Rheumatology (Oxford); 2015 Jan; 54(1):194-5. PubMed ID: 25288787
    [No Abstract]   [Full Text] [Related]  

  • 37. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus.
    Tew GW; Rabbee N; Wolslegel K; Hsieh HJ; Monroe JG; Behrens TW; Brunetta PG; Keir ME
    Lupus; 2010 Feb; 19(2):146-57. PubMed ID: 19946034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of rituximab in patients with systemic lupus erythematosus: an update.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Galarza-Maldonado C; Sandoval-Cruz M; Zamudio-Huerta L; López-Colombo A; Cervera R
    Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small muscle myositis in a patient with systemic lupus erythematosus successfully treated with rituximab.
    Hui M; Andres M; Latief K; Courtney P
    Lupus; 2011 Oct; 20(12):1340-1. PubMed ID: 21768178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.